Actelion Pharmaceuticals Ltd


Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
4123 Allschwil


061 565 65 65
061 565 65 00


Actelion is a biopharmaceutical company headquartered in Allschwil / Basel, Switzerland.

Actelion's first drug, Tracleer, is a therapy for pulmonary arterial hypertonia-approved dual endothelin receptor antagonist in Tablet form. Actelion distributes Tracleer through its own offices in the major international markets, so the United States (based in South San Francisco), the European Union, Japan, Canada, Australia and the USA Switzerland. Actelion, founded in 1997, is a leading global company the exploration of the endothelium. The endothelium separates the vessel wall from the Bloodstream.

Actelion is focused on delivering innovative medicines in areas with high medical needs to be developed, developed and marketed.

Translated by

Data Source: HELP.CH your e-guide ®

Die Gelben Seiten - The Yellow Pages - Les Pages Jaunes - Le Pagine Gialle powered by HELP.CH ®
Copyright © 1996-2020 HELP Media Ltd., Thurgauerstrasse 40, CH-8050 Zürich. All rights reserved. Terms of Use